Careers
Contact
About Trimel
Business Overview
Management Team
Board of Directors
Corporate Governance
Pipeline
Therapeutic Areas
Hypogonadism ("Low T")
Female Sexual Dysfunction
Asthma
Parkinsons
Allergic Rhinitis
Technology
Bioadhesive Intranasal Gel
TriVair
Clinical Trials
News
Recent News
News Archives
Investors
Analyst Coverage
Annual Information Form
Contact Investor Relations
Corporate Fact Sheet
Financial Statements
Presentations / Webcasts
Regulatory Filings
Stock Information
News Archives
Trimel Pharmaceuticals Corporation Announces First Quarter 2013 Financial Results
May 08, 2013
[Read the rest of this article...]
Trimel to Report First Quarter 2013 Results and Host Investor Call
May 02, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Announces Closing of Overallotment Option
May 01, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Corporation Announces Appointment of New Director
April 30, 2013
[Read the rest of this article...]
Trimel Submits New Drug Application for CompleoTRT(TM) to FDA
April 30, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Corporation Completes $40 Million Equity Financing
April 24, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Corporation Announces Terms of $40 Million Equity Financing
April 18, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Corporation Announces Update Regarding Milestone Payment and Amendment to Loan Agreement
April 05, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Corporation Announces Changes to Equity Financing
April 03, 2013
[Read the rest of this article...]
Trimel Announces Fourth Quarter and Year-End 2012 Financial Results
March 25, 2013
[Read the rest of this article...]
Trimel Pharmaceuticals Corporation Announces Equity Financing
March 20, 2013
[Read the rest of this article...]
Trimel Enters Into TriVair™ Development Agreement
March 19, 2013
[Read the rest of this article...]
Trimel Reports Positive CompleoTRT™ Phase III Results for Secondary Efficacy and Safety Endpoints
March 18, 2013
[Read the rest of this article...]
Toronto Stock Exchange Defers Consideration of Shareholder Rights Plan
March 08, 2013
[Read the rest of this article...]
Trimel Adopts Shareholder Rights Plan
February 27, 2013
[Read the rest of this article...]
Trimel Reports Positive CompleoTRT™ Patient Market Research Results
January 07, 2013
[Read the rest of this article...]
Trimel Announces Senior Management Realignment
January 03, 2013
[Read the rest of this article...]
Trimel Announces Positive CompleoTRT™ Phase III Trial Results
December 06, 2012
[Read the rest of this article...]
Trimel Announces Third Quarter 2012 Financial Results and Provides Product Development Update
November 06, 2012
[Read the rest of this article...]
Trimel Reports Physician Market Research results for CompleoTRT™
October 22, 2012
[Read the rest of this article...]